[PMID: 31356792] PubMed record related to this compound for laboratory literature review
Despite the availability of anti-seizure medications, approximately 30% of patients remain drug-resistant, emphasizing the pressing need for alternative therapeutic strategies
Developed by Metabolic Pharmaceuticals in Australia, AOD-9604 was engineered to retain the fat-reducing properties of intact growth hormone while eliminating the undesirable effects on glucose metabolism, insulin sensitivity, and tissue growth
Arch Toxicol
By treating the disease of obesity, they can help prevent and treat a variety of weight-related diseases before they get out of control. What are GLP-1s
Together, they address texture, tone, firmness, and hydration in ways that no single ingredient can